Trilegal Advised On Nephrocare Health Services’ IPO Aggregating ₹8,710.48 Million

Trilegal advised on Nephrocare Health Services’ IPO aggregating ₹8,710.48 million

The leading law firm in India, Trilegal advised on the initial public offering of equity shares (“IPO”) by Nephrocare Health Services Limited (“Nephroplus”), comprising a fresh issue of 7,690,162 equity shares and an offer for sale of 11,253,102 equity shares, aggregating to ₹8,710.48 million. The equity shares were listed on the bourses at a premium of approximately 7%.

Nephroplus is the largest dialysis service provider in Asia and the fifth largest globally in terms of the number of treatments performed in Fiscal 2025. It is the only Indian dialysis services provider that has scaled internationally, with a network of 519 clinics, including 51 clinics across the Philippines, Uzbekistan, and Nepal.

Trilegal advised the syndicate of book running lead managers, namely ICICI Securities Limited, Ambit Private Limited, IIFL Capital Services Limited, and Nomura Financial Advisory and Securities (India) Private Limited.

The Trilegal Capital Markets team advising on the transaction was led by Richa Choudhary (Partner) and Murtaza Zoomkawala (Partner); and comprised Maitreya Rajurkar (Counsel), Shivayana Balodia (Senior Associate), Rainika Malhotra (Associate), Dinank Bhanot (Associate), Yatin Shikharpuri (Associate), and Arnab Goswami (Associate).

Click to know more about Trilegal

If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.